Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0024202,
umls-concept:C0025936,
umls-concept:C0026336,
umls-concept:C0039195,
umls-concept:C0086418,
umls-concept:C0205225,
umls-concept:C0524637,
umls-concept:C0599796,
umls-concept:C0871261,
umls-concept:C0936012,
umls-concept:C1515655,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
pubmed:issue |
6
|
pubmed:dateCreated |
1992-1-23
|
pubmed:abstractText |
In order to characterize primary anti-HLA cytotoxic T cells and especially those involved in graft rejection, we have utilized a transgenic mouse model. Mice (non-transgenic and HLA-transgenic) were grafted with spleen cells originating from H-2-matched transgenic mice expressing HLA-B27 molecules, and cells from graft-draining lymph nodes were tested in CML assay to investigate the primary in vivo induced CTL responses. The results showed that HLA-B27 molecules were able to raise strong primary xenogeneic CTL responses. Results from split-well analysis indicated that although recognition of HLA-B27 by primary CTL induced in nontransgenic recipients is predominantly unrestricted by H-2, a small fraction (ranging from 2% to 27%) of the primary in vivo induced CTL is able to recognize HLA-B27 in an H-2-restricted manner. HLA-specific H-2-restricted CTL had never so far been demonstrated in the primary T cell response. Thus the protocol used in our study for the generation of a primary CTL response seems to provide not only a more appropriate representation of cytotoxic T cells sensitized by a graft, but also to be a more sensitive approach than the usually used in vitro mixed lymphocyte culture.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0041-1337
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
52
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1062-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1721248-Animals,
pubmed-meshheading:1721248-Epitopes,
pubmed-meshheading:1721248-Graft Rejection,
pubmed-meshheading:1721248-H-2 Antigens,
pubmed-meshheading:1721248-Histocompatibility Antigens,
pubmed-meshheading:1721248-Humans,
pubmed-meshheading:1721248-Lymph Nodes,
pubmed-meshheading:1721248-Mice,
pubmed-meshheading:1721248-Mice, Transgenic,
pubmed-meshheading:1721248-Models, Biological,
pubmed-meshheading:1721248-T-Lymphocytes, Cytotoxic,
pubmed-meshheading:1721248-Transplantation Immunology
|
pubmed:year |
1991
|
pubmed:articleTitle |
Analysis of primary HLA-specific cytotoxic T cell response in graft-draining lymph nodes--a transgenic mouse model for in vivo recognition of human MHC antigens.
|
pubmed:affiliation |
U93 INSERM, Saint-Louis Hospital, Paris, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|